Dr. Matthew Walker Facebook and Instagram ad

If your blood pressure is reading above 145 and your last lab report showed your fasting glucose is "on the higher end" — and your doctor handed you a prescription for just the blood pressure without once mentioning those two numbers share the same cause — you need to hear what I'm about to tell you before you fill it. And by the end of this, you're going to be furious. Because three things are happening right now that nobody in that office is explaining to you: One — Your blood is physically thicker and harder to move than it should be. This is not a diet problem. This is a metabolic problem — and it is doing something to your arteries that a blood pressure medication cannot touch. Two — The medication your doctor just prescribed manages the pressure reading it can measure in a fifteen-minute appointment. It does nothing for what is happening inside your bloodstream every hour of every day that is generating that pressure in the first place. Three — There is research showing a compound that actually addresses this at the source. Your doctor has never mentioned it. There is no profit in mentioning it. My name is Dr. Matthew Walker. I've been practicing internal medicine for 24 years. And I need to tell you what high blood pressure actually is in your specific situation — because your doctor got the number right and the cause completely wrong. --- I want to tell you about a patient I'll call Kevin. Fifty-eight years old. Retired engineer. The kind of man who read the fine print on everything, questioned every assumption, and kept spreadsheets on things most people didn't track at all. Kevin had been monitoring his blood pressure at home for almost a year before he came to see me. Every morning, same chair, same arm, same time. His readings had been creeping upward for eighteen months. Not dangerously high. But consistently elevated. 138 over 87. 141 over 89. Never quite coming back down. His previous doctor had ordered a full metabolic panel alongside his blood pressure workup. Fasting glucose: 108. "Borderline," the doctor said. "Keep an eye on it." HbA1c: 5.8. "Technically prediabetic range. We'll check it again in six months." Blood pressure: 144 over 91. "Stage 2 hypertension. We need to address this." His previous doctor's conclusion: two separate problems. Lisinopril for the blood pressure. Dietary recommendations for the glucose. "Reduce sodium, increase exercise, we'll recheck everything in ninety days." Kevin filled the prescription. Took it for fourteen weeks. His blood pressure dropped slightly. His glucose numbers did not move. He felt tired in a way he could not explain — not the normal fatigue of a busy week, but a flatness that sat on him from morning to night. The cough started at week four. Dry, unpredictable, arriving at two in the morning on Tuesday and in the middle of a conversation on Friday. He stopped sleeping through the night. At week ten he noticed something that bothered him more than the cough. He was doing everything he had been told. He had cut sodium dramatically. He was walking forty minutes a day. His diet was cleaner than it had been in twenty years. And his fasting glucose was still 106. Still "borderline." Still inching toward a number that meant something serious. He came to see me at week fourteen with one question that was really two questions wearing the same coat. "Why is my blood pressure a blood pressure problem and my blood sugar a blood sugar problem — when they showed up at the same time, in the same body, and the medication addressed neither one at the source?" It was the best question I had heard in a long time. And the answer changed how I approached this entire class of patient. --- Here is what high blood pressure actually is — and what it is not — for a patient like Kevin. Most people believe high blood pressure comes from one of two things: the heart pumping too hard, or the vessels being too tight. This is what gets taught. This is what gets treated. And for a specific subset of patients — patients like Kevin — it is only the last chapter of a story that started years earlier. The real story begins inside something most doctors never mention. Inside your cells — particularly your muscle cells — there are microscopic transport channels called GLUT4 transporters. Think of them as doors. In a healthy body, when insulin is present, these doors open. Glucose moves out of the bloodstream and into the cells where it is used for energy. Blood sugar stays in a normal range. The blood stays thin, fluid, easy to circulate. But in prediabetes and insulin resistance, something goes wrong with these doors. Insulin shows up and signals them to open — and they do not respond the way they should. The signal weakens. The doors stay partially closed. Glucose that should have entered the cells remains in the bloodstream instead — not for minutes, but for hours. Here is what that does to your blood. When glucose remains trapped in the bloodstream at elevated concentrations for extended periods, it physically changes the properties of the blood itself. The blood becomes denser. Thicker. Stickier. Harder to move. And your heart — which does not get to vote on this — responds the only way it knows how. It increases force. It pushes harder. Meanwhile, the glucose that isn't being cleared is not sitting passively. It is grinding against the inner walls of your arteries with every heartbeat. Slowly. Hour after hour. Day after day. This is what I call silent arterial decline — and it is happening long before any doctor notices anything alarming enough to name. Your arteries respond to this constant friction by stiffening. They lose their elasticity. What were once flexible, responsive vessels that could expand and contract with changing demands become something much closer to rigid pipes. Blood forced through stiffened pipes requires more pressure to move. And this is where the standard blood pressure picture — the heart pumping too hard, the vessels too tight — finally arrives. But by the time it shows up as a reading above 140, it has been building for years. The trapped glucose has been making the blood thicker. The arteries have been slowly stiffening. The dysfunction was always metabolic. The blood pressure reading is simply the final, measurable symptom of a process that has been running silently for a long time. This is what Kevin's body was telling us. Not two separate problems. One problem, showing up in two different lab values at the same time. The clinical setting does not create the problem. The lab report reveals it. And Lisinopril is not the solution. Lisinopril forces your vessels to relax by blocking the enzyme that causes constriction. It chemically manages the output. It does not reduce the glucose load making the blood thicker in the first place. It does not restore GLUT4 transporter function so that glucose can actually clear from the bloodstream naturally. It does not stop the silent arterial decline that is happening every hour the blood is denser than it should be. The moment you stop taking it, your vessels are under exactly the same metabolic burden as before. Because the burden was never addressed. Managed, not fixed. Kevin looked at me steadily. "So the blood pressure isn't the primary problem. The glucose trapped in my bloodstream is making my blood thicker, and my heart is compensating for that." "Correct." "And my arteries are stiffening from the glucose grinding against them, which is making the pressure worse on top of that." "Correct." "And Lisinopril forces the vessels open but does nothing about the glucose load creating the need for that force in the first place." "Correct." "Then why did my previous doctor treat them as two separate problems when they share the same mechanism?" I did not have a good answer for that. What I did have was research. --- The compound is called cinnamaldehyde. It is the active molecule in true Ceylon cinnamon — not the cheap Cassia variety sold in grocery stores and the overwhelming majority of supplements, but a specific botanical species sourced from Sri Lanka, with a chemical profile that is fundamentally different. Here is what cinnamaldehyde does that matters for patients like Kevin. It acts directly on GLUT4 transporters. Not on the vessels. Not on the heart. On the root of the problem — the cellular doors that stopped responding to insulin properly. Cinnamaldehyde helps restore the signal. The transporters begin opening again. Glucose begins clearing from the bloodstream at the rate it was always supposed to. When the glucose load drops, the blood becomes thinner. Less dense. Easier to move. When the blood is easier to move, the heart no longer needs to generate the same compensatory pressure. When the glucose is no longer grinding against arterial walls at elevated concentrations hour after hour, the silent arterial decline slows. The stiffened pipes begin to recover their elasticity. The pressure drops — not because a drug forced the vessels open, but because the metabolic burden creating that pressure was reduced at the source. Now — before you say cinnamon doesn't work, I've tried cinnamon — let me explain precisely why what you tried failed. Every cinnamon supplement on the pharmacy shelf almost certainly contains Cassia cinnamon. Cassia is inexpensive. It fills the vast majority of cinnamon products globally. And it contains a compound called coumarin — which at the concentrations found in Cassia is linked to liver toxicity with regular use. That is not a minor footnote. It is why studies on cinnamon produce inconsistent results — because most of them are not using the right botanical species, and the ones that are often use uncontrolled concentrations of the active compound. True Ceylon cinnamon contains negligible coumarin. Completely different safety profile. But more importantly — even with genuine Ceylon, a standard powder or capsule delivers inconsistent concentrations of cinnamaldehyde. The active molecule. The one that actually reaches the GLUT4 transporters and restores the signal. What the research requires — and what makes a clinical difference — is a standardized, concentrated extract. Not powder. Not generic oil. A 12:1 concentrated extract, standardized specifically for cinnamaldehyde content, so you know exactly what is being delivered to the cells that need it. And then there is the absorption problem. Cinnamaldehyde is fat-soluble. Taken without fat, a significant portion is lost before it can be properly absorbed. The delivery system that matches the research uses MCT oil — medium-chain triglycerides — as a carrier. Fat-soluble compound delivered with fat. Absorption that actually reaches the cells at therapeutic concentrations. This is why the cinnamon product from the pharmacy did nothing. Wrong species. Probable coumarin exposure. Unverified cinnamaldehyde concentration. No fat-based delivery. A completely different thing from what the research shows actually works. The research on standardized cinnamaldehyde extract shows something I did not expect the first time I looked closely at the numbers. Fasting blood glucose came down — not briefly, but sustained. Because the GLUT4 transporters were responding again, glucose was clearing from the bloodstream the way it was always supposed to. It was not a temporary spike-and-drop. It was a measurable shift that held over time. Blood pressure followed. When the glucose load drops, the blood moves more easily. When the blood moves more easily, the heart does not need to push as hard. Systolic and diastolic both came down — not from chemical vessel suppression, but from reduced metabolic demand on a circulatory system that was no longer fighting thickened blood. HbA1c — the three-month blood sugar average — improved over the study window. That number cannot be temporarily manipulated by what you ate the day before a test. When HbA1c moves in the right direction, the metabolic correction is holding. And across the research: no meaningful adverse effects. No cough. No fatigue. No dizziness when standing. That last point mattered specifically for Kevin. Cinnamaldehyde does not force anything. It restores a signal. When the GLUT4 transporters open properly, glucose clears through the mechanism that was always supposed to clear it. The body regulates itself. That is not the same thing as a drug holding a door open that your body has forgotten how to open on its own. I walked Kevin through what the research showed, and with his full understanding, we moved him off the Lisinopril. I started him on Metabolae — a 12:1 concentrated extract of true Ceylon cinnamon, standardized for cinnamaldehyde, delivered in an MCT oil base for full fat-soluble absorption. The reason I chose Metabolae specifically: most brands that say "Ceylon cinnamon" on the label either use Cassia and mislabel it, use genuine Ceylon in an unstandardized powder with no verified cinnamaldehyde concentration, or use both under vague labeling. If the extract is not standardized for cinnamaldehyde content, you are not delivering the compound the research tested. You are taking a spice. Metabolae verifies Sri Lanka-sourced true Ceylon, standardizes the 12:1 extract, specifies cinnamaldehyde content, and uses MCT oil delivery in every soft gel. That matters when you are trying to match what the research actually found. --- Kevin's readings in week one: no significant change. Cinnamaldehyde works through metabolic restoration — not chemical suppression. GLUT4 function does not recover in seventy-two hours. I told him to track his fasting glucose alongside his blood pressure and to be patient. Week two: fasting glucose 101. Blood pressure 138 over 86. Small movement. More importantly — no cough. No fatigue. He was sleeping through the night again. Week four: fasting glucose 96. Blood pressure 133 over 83. Consistent. Week six: I had him come in. His previous blood pressure reading in this office: 144 over 91. This reading: 129 over 79. A 15-point drop in systolic. His fasting glucose that morning: 94. "The blood is moving more easily," he said. "Yes," I said. "Because there is less in the way." He looked at his home tracking sheet for a long moment. "Fourteen weeks on Lisinopril. Glucose never moved. Six weeks on this and both numbers are coming down together." "Lisinopril manages the pressure," I said. "Metabolae is reducing the metabolic burden creating it. They are not doing the same thing." Kevin came back for his three-month follow-up. Blood pressure: 124 over 77. Fasting glucose: 91. HbA1c: 5.4. Out of prediabetic range. The two numbers his previous doctor had treated as entirely separate problems — that had sent him through fourteen weeks of a persistent cough, unexplained fatigue, disrupted sleep, and zero actual metabolic improvement — were both moving in the same direction at the same time. Because they had always had the same cause. --- If you are reading this and you recognized your own numbers in the opening — elevated blood pressure alongside fasting glucose that is "on the higher end," a doctor who treated them as separate problems, a prescription that addressed the reading without once touching the mechanism — I want you to understand something. High blood pressure in the context of prediabetes and insulin resistance is not a circulatory problem with a circulatory solution. It is a metabolic problem. Glucose trapped in the bloodstream makes the blood thicker and harder to circulate. The heart compensates with more force. The glucose grinds against arterial walls hour after hour, producing silent arterial decline long before any number becomes alarming enough to treat. The arteries stiffen. Blood forced through stiffened pipes requires more pressure. The reading above 140 is the last chapter — not the first. Medication manages the number. It does not reduce the metabolic burden producing it. Managed, not fixed. The moment you stop, the blood is exactly as thick as it was before. Because the GLUT4 transporters were never addressed. The signal was never restored. Cinnamaldehyde from a properly standardized, properly sourced, properly delivered Ceylon cinnamon extract restores that signal. GLUT4 transporters begin responding to insulin again. Glucose clears from the bloodstream. Blood viscosity drops. The heart decompresses. The glucose stops grinding against the arterial walls. The silent arterial decline slows. The metabolic burden lifts — and the pressure follows. The Ceylon sourcing is not a marketing detail — it is the entire foundation. Most products use Cassia. Cassia contains coumarin at concentrations linked to liver toxicity with regular use. If the label does not specify Sri Lanka-sourced true Ceylon with verified species identification, you do not have the right compound — and you may be doing harm in the process. The 12:1 extract concentration matters just as much. Cinnamon powder delivers inconsistent and clinically insufficient cinnamaldehyde. Without standardization of the active molecule, you are taking a spice. Not a therapeutic intervention. A spice. And the MCT oil delivery is what determines whether any of it reaches the cells that actually need it. Cinnamaldehyde is fat-soluble. Without a fat-based carrier, absorption is compromised and the compound does not arrive at the GLUT4 transporters in the concentrations the research required. This is not a bonus feature. It is the delivery mechanism that makes everything else work. Metabolae addresses all three. Sri Lanka-sourced true Ceylon cinnamon. A 12:1 concentrated extract with standardized cinnamaldehyde content. Delivered in an MCT oil base in every soft gel. It is the formulation built around what the research actually tested — not a cinnamon product that borrowed the marketing language without the mechanism. I want to be direct about one thing: this is not a one-week fix. Arterial stiffness does not develop in a weekend — and it does not reverse in one. The therapeutic window for GLUT4 restoration, blood viscosity reduction, and early arterial recovery is a minimum of three continuous months. This is why the protocol that produces real results is the 90-day approach — two bags with a third included — so the body has the uninterrupted time it needs to do what it was always designed to do. Give it six to eight weeks. Track your fasting glucose and your blood pressure together. Watch both move in the same direction — because for the first time, you are addressing the same problem with the right tool. 90-day money-back guarantee. If your numbers do not improve, you pay nothing. --- One path: Fill the prescription. Accept the cough, the fatigue, the disrupted sleep. Watch your blood pressure drop slightly while your glucose stays exactly where it was. Treat the downstream symptom indefinitely while the metabolic engine producing it keeps running. Managed, not fixed. Another path: Restore the signal. Reduce the burden. Give your cells back the ability to do what they were designed to do — clear glucose from the bloodstream so your blood is thinner, your vessels can relax naturally, and your heart is no longer compensating for a problem nobody named correctly. The elevated blood pressure and the borderline glucose are not two separate problems. They are the same problem — asking for the right tool. — Dr. Matthew Walker, MD. Internal Medicine, 24 years. --- P.S. — The reason your doctor treated these as two separate problems is not incompetence. It is that they have fifteen minutes, two lab values, and two standard pharmaceutical protocols — one for each. The research on GLUT4 activation and cinnamaldehyde exists. It has been published. It simply generates no prescription revenue, which means it never becomes part of the standard training or the standard of care. You have to find it yourself. P.P.S. — Every month the GLUT4 dysfunction goes unaddressed is another month glucose remains trapped in your bloodstream longer than it should. Every month the blood is thicker than it should be, the arteries absorb more friction than they should, and the silent arterial decline advances a little further. Kevin waited eighteen months before he connected the two numbers. That is eighteen months of arterial stiffening that required additional time to reverse. The best time to address the mechanism was before the readings started climbing. The second best time is now.